AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $426,228 | -95.8% | 20,160 | -91.7% | 0.00% | -96.4% |
| Q1 2021 | $10,072,000 | -3.9% | 241,987 | 0.0% | 0.08% | +1.2% |
| Q4 2020 | $10,486,000 | -20.7% | 241,987 | -35.9% | 0.08% | -33.1% |
| Q3 2020 | $13,216,000 | +718.3% | 377,605 | +844.0% | 0.12% | +210.0% |
| Q1 2016 | $1,615,000 | -46.6% | 40,000 | -14.2% | 0.04% | -50.6% |
| Q4 2015 | $3,025,000 | -8.1% | 46,600 | 0.0% | 0.08% | 0.0% |
| Q3 2015 | $3,290,000 | -38.3% | 46,600 | -2.9% | 0.08% | -27.0% |
| Q2 2015 | $5,335,000 | +126.3% | 48,000 | +92.0% | 0.11% | +131.2% |
| Q1 2015 | $2,358,000 | -15.8% | 25,000 | 0.0% | 0.05% | -18.6% |
| Q4 2014 | $2,801,000 | – | 25,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |